Business Description
Supriya Lifescience Ltd
ISIN : INE07RO01027
Description
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 20.84 | |||||
Equity-to-Asset | 0.89 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | 0.03 | |||||
Interest Coverage | 144.99 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 22.03 | |||||
Beneish M-Score | -1.06 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -22.8 | |||||
3-Year EBITDA Growth Rate | -26.5 | |||||
3-Year EPS without NRI Growth Rate | -26.4 | |||||
3-Year Book Growth Rate | 14.2 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 22.91 | |||||
9-Day RSI | 35.15 | |||||
14-Day RSI | 42.29 | |||||
6-1 Month Momentum % | 45.4 | |||||
12-1 Month Momentum % | 55.67 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 6.26 | |||||
Quick Ratio | 4.76 | |||||
Cash Ratio | 1.83 | |||||
Days Inventory | 149.74 | |||||
Days Sales Outstanding | 55.91 | |||||
Days Payable | 80.84 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.16 | |||||
Dividend Payout Ratio | 0.04 | |||||
Forward Dividend Yield % | 0.16 | |||||
5-Year Yield-on-Cost % | 0.16 | |||||
3-Year Average Share Buyback Ratio | -46.6 | |||||
Shareholder Yield % | 0.75 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 52.12 | |||||
Operating Margin % | 28.68 | |||||
Net Margin % | 22.11 | |||||
FCF Margin % | -7.76 | |||||
ROE % | 17.16 | |||||
ROA % | 14.9 | |||||
ROIC % | 19.09 | |||||
ROC (Joel Greenblatt) % | 30.67 | |||||
ROCE % | 23.02 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 24.45 | |||||
PE Ratio without NRI | 24.05 | |||||
Price-to-Owner-Earnings | 79.6 | |||||
PS Ratio | 5.4 | |||||
PB Ratio | 3.91 | |||||
Price-to-Tangible-Book | 3.92 | |||||
Price-to-Operating-Cash-Flow | 44.48 | |||||
EV-to-EBIT | 16.95 | |||||
EV-to-EBITDA | 15.56 | |||||
EV-to-Revenue | 5.2 | |||||
EV-to-FCF | -69.02 | |||||
Price-to-Graham-Number | 2.24 | |||||
Price-to-Net-Current-Asset-Value | 9.17 | |||||
Price-to-Net-Cash | 96.77 | |||||
Earnings Yield (Greenblatt) % | 5.91 | |||||
FCF Yield % | -1.44 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Supriya Lifescience Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 5,445.38 | ||
EPS (TTM) (₹) | 14.96 | ||
Beta | 0 | ||
Volatility % | 32.29 | ||
14-Day RSI | 42.29 | ||
14-Day ATR (₹) | 14.388603 | ||
20-Day SMA (₹) | 387.8725 | ||
12-1 Month Momentum % | 55.67 | ||
52-Week Range (₹) | 231.05 - 423.5 | ||
Shares Outstanding (Mil) | 80.48 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Supriya Lifescience Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Supriya Lifescience Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
Supriya Lifescience Ltd Frequently Asked Questions
What is Supriya Lifescience Ltd(BOM:543434)'s stock price today?
When is next earnings date of Supriya Lifescience Ltd(BOM:543434)?
Does Supriya Lifescience Ltd(BOM:543434) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |